GlassScriptPhysician profile
Obiageli Obiako
NPI 1255951141
$394.29
in general payments reported to CMS, 2019-2025
10 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $52.88 · 2024: $169 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $130.85 | 2024-2025 | |
| Novo Nordisk INC | $43.82 | 2024 | Ozempic, Rybelsus |
| Medtronic, INC. | $42.05 | 2023-2024 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Kiniksa Pharmaceuticals International, Plc | $37.43 | 2024 | Arcalyst |
| Atricure, INC. | $35.95 | 2025 | Synergy Ablation System |
| Alnylam Pharmaceuticals INC. | $25.45 | 2025 | Onpattro |
| Chiesi USA, INC. | $23.02 | 2024 | Kengreal, Cleviprex |
| Genzyme Corporation | $21.85 | 2023 | |
| Pfizer INC. | $17.28 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.59 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Obiageli Obiako listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.